Genetic Mutation Led To Famous Biker's Rare Condition
Lee Rannals for redOrbit.com - Your Universe Online An international team of scientists writing in the journal Nature Genetics has helped to identify a single genetic mutation in National Paracycling Champion Tom Staniford that has led to his...
Latest genomics Stories
DALLAS, June 18, 2013 /PRNewswire/ -- The "Bioinformatics Market By Sector (Molecular Medicine, Agriculture, Research & Forensic), Segment (Sequencing Platforms, Knowledge Management Tools & Data Analysis Services) & Application (Genomics, Proteomics & Drug Design) - Global Forecasts to 2017", analyzes and studies the Major Market Drivers, Restraints, and Opportunities in North America, Europe, Asia-Pacific and Rest of World. Browse -...
INNSBRUCK, Austria, June 18, 2013 /PRNewswire/ -- On 1 June 2013, Dr Wulf Fischer-Knuppertz, took over as Chief Executive Officer (CEO) of the internationally operating biotech company BIOCRATES Life Sciences AG. He will from now on be responsible for the company's corporate and strategic management. For more than 25 years, Dr Fischer-Knuppertz has held various leading positions in the diagnostics and pharmaceutical industries. Most recently, 56-year-old...
GB HealthWatch has just released an innovative Weight Control eTool, a highly personalized online weight loss program based on an individual’s genes, food preferences, and behavioral traits. This tool is the first taste of what is come from a nutritional genomics company poised on the cutting edge of preventive health care; free access is available in June. San Diego, CA (PRWEB) June 17, 2013 Body weight is the result of constant interactions between a person’s genes and environment....
Fulgent Therapeutics, a CLIA Certified Laboratory, announces today the inclusion of BRCA1 and BRCA2 analysis into its Hereditary Cancer Panel. Temple City, CA (PRWEB) June 14, 2013 Fulgent Therapeutics LLC, a CLIA Certified Laboratory, announces the inclusion of BRCA1 and BRCA2 analysis to its Hereditary Cancer Panel. Fulgent Therapeutics is excited to add these key targets, making it the most comprehensive test for cancer risk assessment available. Fulgent Therapeutics Hereditary...
“DNA Sequencing 2013: Market Developments, Growth Areas and Opportunities” and “Global DNA Sequencing Products Market 2012-2016” are new market research reports added to the online library of ReportsnReports.com. Dallas, Texas (PRWEB) June 13, 2013 Biopharm Reports has carried out a global market study of the DNA sequencing field, involving the participation of 233 DNA sequencers and decision-makers in more than 50 countries. This study, now available through ReportsnReports.com,...
Statement from InformedDNA Chief Executive Officer, David P. Nixon ST. PETERSBURG, Fla., June 13, 2013 /PRNewswire-USNewswire/ -- "Today's Supreme Court ruling is an important win for patients everywhere because this decision supports patient choice. This ruling opens the door for additional companies to provide these services. Ultimately, more patients will have timely, affordable access to these important tests, when they are needed. "InformedDNA believes that an equally...
In effort to increase access to potentially lifesaving BRCA1 and BRCA2 tests, DNATraits can now offer tests for $995, a fraction of the cost of similar tests prior to the court decision HOUSTON, June 13, 2013 /PRNewswire/ -- Thanks to today's U.S. Supreme Court decision opening the door to greater access to genetic medicine by American patients and their health care providers, testing for genes specifically linked to breast, ovarian and other cancers will now be more widely available...
BETHESDA, Md., June 13, 2013 /PRNewswire-USNewswire/ -- Today, The Supreme Court of the United States (SCOTUS), in a unanimous decision, held that natural isolated DNA is not patentable. This is a thrilling victory for patients and ACMG is proud to have been a plaintiff on this important case. "We hold that a naturally occurring DNA segment is a product of nature and not patent eligible merely because it has been isolated," Justice Clarence Thomas said. As background, with breast...
microRNA assay determined reasonable and necessary for providing an important niche in pathologic diagnoses of Cancer of Unknown Primary PHILADELPHIA and REHOVOT, Israel, June 13, 2013 /PRNewswire/ -- Rosetta Genomics Ltd. (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostics, announces that Novitas Solutions, the designated Medicare Administrative Contractor (MAC) for the Company's microRNA-based diagnostic assays, has issued for notice the final...
Gaithersburg, Md., June 13, 2013 /PRNewswire/ -- GeneDx, one of the world's foremost genetic testing laboratories and a subsidiary of Bio-Reference Laboratories, Inc. (NASDAQ: BRLI) announced today its intention to launch a suite of comprehensive genetic tests for inherited cancers including BRCA1 and BRCA2 genes, given the Supreme Court's ruling in the Association for Molecular Pathology vs. Myriad Genetics case. GeneDx, which was the first commercial laboratory to utilize next...
Latest genomics Reference Libraries
According to the Bureau of Labor Statistics, a highly technical field like genetic engineering can be a beacon of stability and growth in today’s slumping job market. Genetic engineers, or biomedical engineers, are expected to see their career prospects grow as new technological advances drive an ever greater demand for individuals to specialize in this field. The National Human Genome Research Institute (NHGRI) says that a position as a genetic engineer typically requires at least a...
